Canada markets close in 3 hours 41 minutes

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.34+0.00 (+0.09%)
As of 12:19PM EDT. Market open.
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts11111110
Avg. Estimate-0.17-0.14-0.62-0.37
Low Estimate-0.32-0.18-0.84-0.82
High Estimate-0.14-0.1-0.51-0.08
Year Ago EPS-0.4-0.19-1.18-0.62
Revenue EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts10101110
Avg. Estimate98.32M103.31M401.79M475.84M
Low Estimate96.66M101.5M394M383M
High Estimate101.09M105.81M408.07M512.18M
Year Ago Sales82.49M85.95M331.41M401.79M
Sales Growth (year/est)19.20%20.20%21.20%18.40%
Earnings History2023-06-292023-09-292023-12-302024-03-30
EPS Est.-0.23-0.23-0.24-0.21
EPS Actual-0.4-0.19-0.31-0.17
Difference-0.170.04-0.070.04
Surprise %-73.90%17.40%-29.20%19.00%
EPS TrendCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.17-0.14-0.62-0.37
7 Days Ago-0.16-0.13-0.63-0.35
30 Days Ago-0.16-0.13-0.61-0.34
60 Days Ago-0.16-0.12-0.59-0.3
90 Days Ago-0.16-0.15-0.72-0.39
EPS RevisionsCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days3473
Up Last 30 Days3473
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days5526
Growth EstimatesBCRXIndustrySector(s)S&P 500
Current Qtr.57.50%N/AN/AN/A
Next Qtr.26.30%N/AN/AN/A
Current Year47.50%N/AN/AN/A
Next Year40.30%N/AN/AN/A
Next 5 Years (per annum)44.80%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A